Screener
Altisource Portfolio Solutions ASPS Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $51.92M+23.9% | $50.66M+17.0% | $47.58M+9.5% | $42.34M+3.2% | $41.91M+3.4% | ||
| $39.8M+30.2% | $37.84M+25.1% | $34.47M+14.5% | $31.13M+8.9% | $30.56M+7.4% | ||
| $12.12M+6.8% | $12.82M-1.6% | $13.11M-1.6% | $11.21M-9.9% | $11.35M-6.0% | ||
| 23.4%-3.7pp | 25.3%-4.8pp | 27.6%-3.1pp | 26.5%-3.8pp | 27.1%-2.7pp | ||
| $11.36M+4.9% | $11.69M+19.3% | $11.39M+13.0% | $10.27M-8.0% | $10.83M-1.3% | ||
| $764K+46.6% | $1.13M-65.0% | $1.73M-46.8% | —— | $521K-52.9% | ||
| 1.5%+0.2pp | 2.2%-5.2pp | 3.6%-3.8pp | —— | 1.2%-1.5pp | ||
| $2.16M-8.9% | $2.13M-18.6% | $2.11M-57.3% | $2.25M-76.5% | $2.37M-76.2% | ||
| -$1.76M+19.6% | -$1.17M+61.4% | -$1.37M+82.4% | -$1.56M+82.6% | -$2.19M+77.2% | ||
| -$993K+40.4% | -$43K-123% | $356K+108% | -$8.14M+2.8% | -$1.67M+80.4% | ||
| $406K-38.5% | $472K+103% | $887K+19.5% | -$1.01M-392% | $660K-18.4% | ||
| -$1.4M+39.8% | -$515K-103% | -$531K+89.9% | —— | -$2.33M+75.0% | ||
| -2.7%+2.9pp | -1%-39.5pp | -1.1%+11.0pp | —— | -5.5%+17.4pp | ||
| -$0.12+45.5% | -$0.05-103% | -$0.06+91.9% | —— | -$0.22+91.6% | ||
| $2.23M+18.0% | $2.65M-43.5% | $3.21M-31.8% | -$4.44M-316% | $1.89M-26.6% | ||
| 4.3%-0.2pp | 5.2%-5.6pp | 6.7%-4.1pp | -10.5%-15.5pp | 4.5%-1.8pp | ||
| $764K+46.6% | $1.13M-65.0% | $1.73M-46.8% | -$5.89M-1,108% | $521K-52.9% |
FAQ
- What is Altisource Portfolio Solutions's revenue?
- Altisource Portfolio Solutions (ASPS) generated $192.5M in revenue over the trailing twelve months, up 13.5% year over year.
- What are Altisource Portfolio Solutions's profit margins?
- Gross margin is 25.6% and operating margin is 4.5%, with a 0.2% net margin.
- Where does Altisource Portfolio Solutions's income statement data come from?
- Every line is extracted from Altisource Portfolio Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
